Terns Pharmaceuticals, Inc. (TERN)
40.59
-0.91
(-2.19%)
USD |
NASDAQ |
Dec 30, 16:00
40.60
+0.01
(+0.02%)
After-Hours: 20:00
Terns Pharmaceuticals Total Assets (Quarterly): 301.65M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 218.45M |
| Ligand Pharmaceuticals, Inc. | 1.477B |
| ADMA Biologics, Inc. | 568.69M |
| Viking Therapeutics, Inc. | 739.42M |
| Cidara Therapeutics, Inc. | 518.65M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.58M |
| Shareholders Equity (Quarterly) | 284.07M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |